USPTO serial 97597400
CANARY MEDICAL
Reviewed by CopyMark Law Group
Status 734Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- RADEMACHER, APRIL LUEDERS
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with CANARY MEDICAL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $324*
Plus Government fees of $125
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kevin S. Costanza
Kevin S. Costanza SEED IP LAW GROUP LLP701 FIFTH AVENUESUITE 5400SEATTLE, WA 98104Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Angioplasty rings which measure blood flow, blood pressure and blood volume; artificial heart valves; Cardiovascular devices, namely, synthetic coronary stent grafts; coronary stents; implantable medical devices adapted for recording and transferring internal patient data and for monitoring the integrity and function of the device during use; Implants consisting of artificial materials; Joint prostheses; joint prostheses adapted for recording and transferring internal patient data and for monitoring the integrity and function of the implanted prosthesis during use; medical, surgical and orthopaedic implants made of artificial materials; medical, surgical, cardiovascular, neurovascular, pulmonary, spinal, aesthetic and orthopaedic implants, prostheses, components, devices, apparatus and instruments; medical devices, namely, medical sensors that are implanted or inserted into the human body used to continuously monitor the concentration of glucose in the human body and accessories therefor, namely, receivers, sensor housings and sensor insertion devices; medical devices, namely, medical sensors that are implanted or inserted into the human body used to continuously monitor bleeding in the human body and accessories therefor, namely, receivers, sensor housings and sensor insertion devices; Non-implantable and portable medical and diagnostic devices, namely, patient monitors and wearable patient monitor patches and ingestible patient sensors for monitoring, measuring and capturing physiologic data, environmental data, treatment data, data related to medications, pharmaceuticals, and supplements, and data transmitted by medical devices; medical devices, namely, wireless receivers and transmitters used for capturing patient physiologic data, patient environmental data, patient treatment data, data related to patient medications, pharmaceuticals, and supplements, and patient data transmitted by medical devices, ingestible sensors, implants, and conductive packaging and labels; Implantable medical devices, namely, patient monitors for monitoring and capturing physiologic data, environmental data, treatment data, data related to medications, pharmaceuticals, and supplements, and data transmitted by medical devices; orthopedic joint implants made of artificial materials; sensors specially adapted for use with medical devices for determining integrity, function and usage of integrated component parts in the nature of batteries and remote power sources, and also featuring a microcontroller, wireless transceiver, and memory electronics for use in recording and transferring internal patient data to a medical device external to the body comprised of a wireless transceiver, power source, microcontroller, and primary transceiver for communication with a medical implant; system consisting primarily of an artificial orthopedic implant, a wearable medical device, a charger for the wearable medical device, and computer hardware and software for providing kinematic data and information to medical professionals; systems for aneurism stent graph comprised primarily of medical sensors for measuring blood pressure, blood flow volume, and heart rate, stent graph leaks, and also featuring computer hardware and integrated software for communicating and transmitting sensor data; systems for hypertension monitoring comprised primarily of medical sensors for measuring blood pressure, blood flow volume, and heart rate, and also featuring computer hardware and integrated software for communicating and transmitting sensor data; systems for in vivo cardiovascular blood pressure monitoring comprised primarily of medical sensors for measuring blood pressure, blood flow volume, and heart rate, and also featuring computer hardware and integrated software for communicating and transmitting sensor data; systems specially adapted for use with medical devices for monitoring the integrity and function of a medical implant comprised primarily of sensors for determining battery integrity, life and usage, sensor and system integrity, life and usage, and medical implant integrity, functionality and usage, and also featuring computer hardware and integrated software for communicating and transmitting sensor data; wearable medical device | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 28, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 27, 2026 | EX5G | SOU EXTENSION 5 GRANTED | — |
| May 21, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 20, 2026 | EXT5 | SOU EXTENSION 5 FILED | — |
| Nov 21, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 21, 2025 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Nov 20, 2025 | EXT4 | SOU EXTENSION 4 FILED | — |
| Nov 20, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 21, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 21, 2025 | EX3G | SOU EXTENSION 3 GRANTED | — |
| May 20, 2025 | EXT3 | SOU EXTENSION 3 FILED | — |
| May 20, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 28, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 27, 2025 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Feb 27, 2025 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Nov 19, 2024 | EXT2 | SOU EXTENSION 2 FILED | — |
| Nov 19, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 30, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 29, 2024 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Apr 29, 2024 | EXT1 | SOU EXTENSION 1 FILED | — |
| Apr 29, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 21, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Sep 26, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 26, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 6, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 22, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 27, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 27, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 27, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 27, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 27, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 27, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 28, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 22, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 22, 2022 | NWAP | NEW APPLICATION ENTERED | — |